AANA October 2025 Journal Course: Methadone or Buprenorphine: Equal in Treating Opioid Dependent Parturients?

Catalog

Create Account

Availability

On-Demand

Expires on Oct 05, 2026

Cost

Member: $0.00

Non-Member: $50.00

Resident Member: $0.00

Credit Offered

1 Class A Credit

This AANA Journal Course explores the comparative effectiveness of methadone and buprenorphine in treating opioid-dependent parturients. Learners will examine the pharmacologic differences, maternal and neonatal outcomes, and clinical implications of each medication within the context of opioid use disorder during pregnancy. The course reviews current evidence-based practices, safety profiles, and evolving regulations influencing medication-assisted treatment (MAT). Through analysis of recent studies, participants will gain a deeper understanding of how methadone and buprenorphine impact maternal health, fetal development, neonatal abstinence syndrome (NAS), and overall treatment accessibility, equipping anesthesia providers to deliver informed, equitable, and safe care to pregnant patients with OUD.

Learning Outcomes:

Compare and contrast the pharmacological profiles, maternal outcomes, and neonatal outcomes associated with methadone and buprenorphine use in opioid-dependent parturients.
Evaluate current evidence-based practices and safety guidelines for initiating and managing medication-assisted treatment with methadone or buprenorphine in pregnant patients.
Identify barriers to treatment access, including regulatory, socioeconomic, and racial disparities and discuss strategies to improve care and equity for parturients with opioid use disorder.

This program has been prior approved by the American Association of Nurse Anesthesiology for 1.00 Class A CE credits; Code Number 1046194; Expiration Date 10/5/2026.

Cindi Dabney, PhD, DNP, CRNA
Nicole Nelson, BSN, RN
Michelle Canale, DNP, CRNA
Sarah Jingying Zhang, PhD, CRNA

None of the content experts for this activity have relevant financial relationship(s) to disclose with ineligible companies.

Accreditation Information:
The American Association of Nurse Anesthesiology is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

AANA is an approved provider by the California Board of Registered Nursing, CEP #10862.

Disclosure Statement:
Any relevant relationship between an ineligible company and an individual with the ability to influence clinical content will be identified by the Nurse Planner within the activity. Any relevant relationship between an ineligible company and an individual with the ability to influence clinical content has been mitigated.

Post-Test Attempt Notice:
A minimum passing score of 80% is required to pass this course. You have TWO opportunities to achieve a passing score. If you fail to achieve a passing score of 80%, you will not receive CE credit for this course.

Content Disclaimer:
The views, information, or opinions expressed within the videos and audio are solely those of the individuals involved and do not necessarily represent those of the American Association of Nurse Anesthesiology.

Course content has been prepared by the presenter/developer, and each viewer agrees that the presenter/developer is solely responsible for the content and the accuracy thereof. The viewer agrees that the American Association of Nurse Anesthesiology has no responsibility or liability for the accuracy or completeness of the content.

Refund Policy:
Continuing education activities are nonrefundable.